publication venue for
- USE OF ONCOLYTIC VIRAL VACCINES TO TREAT CANCER 2014
- Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer. 2009
- Gross thymic extract, Thymax, induces apoptosis in human breast cancer cells in vitro through the mitochondrial pathway. 2008
- A RAPID METHOD FOR THE DETERMINATION OF ORGAN SPECIFIC TOXICITY USING HUMAN EXPLANT CULTURES 1987
- DEVELOPMENT OF A MODEL FOR THE STUDY OF TRANSFORMATION IN CULTURED HUMAN-TISSUES 1987
- FAVORABLE DIFFERENTIAL SENSITIVITIES OF NORMAL AND TUMOR EXPLANT CULTURES TO COMBINED TREATMENT WITH RADIATION AND APPROPRIATE CYTOTOXIC AGENTS 1987
- Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art. 42:3261-3274. 2022
- Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis. 39:2277-2287. 2019
- Therapeutic Pelvic Lymph Node Dissection in the Second Gestational Trimester: A Case Report and Literature Review. 37:2487-2490. 2017
- Impact of temperature on cell death in a cell-culture model of hepatocellular carcinoma.. 32:915-921. 2012
- Cell to cell interactions influence sensitivity of liver cell lines during hyperthermia.. 31:3713-3717. 2011
- Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor.. 31:3429-3432. 2011
- Systemic changes of tryptophan catabolites via the indoleamine-2,3-dioxygenase pathway in primary cervical cancer.. 31:2629-2635. 2011
- Effect of hyperthermia on liver cell lines: important findings for thermal therapy in hepatocellular carcinoma.. 31:1583-1588. 2011
- In vitro analysis of the herbal compound Essiac.. 27:3875-3882. 2007
- An in vivo analysis of the herbal compound essiac.. 26:3057-3063. 2006
- Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma.. 19:749-756. 1999
- Lymphoedema of the arm after primary treatment of breast cancer.. 18:2235-2236. 1998
- Benzodiazepine-induced inhibition of human malignant melanoma (M-6) cell growth.. 16:1259-1263. 1996
- Energetic characteristics of cisplatin resistant ovarian carcinoma cells.. 16:443-447. 1996
- Differential expression of transforming growth factor alpha, adhesions molecules and integrins in primary, metastatic liver tumors and in liver cirrhosis.. 15:559-562. 1995
- Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain.. 14:1469-1475. 1994
- Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease.. 13:2229-2237. 1993
- Chemotherapy agents and the induction of late lethal defects.. 11:1605-1608. 1991
- Induction of c-myc oncoprotein and of cellular proliferation by radiation in normal human urothelial cultures.. 11:1609-1612. 1991
- The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines.. 11:41-47. 1991
- The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.. 11:235-239. 1991
- THE INVITRO EFFECTS OF LONIDAMINE COMBINED WITH CISPLATIN IN HUMAN SMALL-CELL LUNG-CANCER CELL-LINES. 11:235-239.